Design of Novel Antisense Nucleic Acids with Resistance for Nuclease digestion

抗核酸酶消化的新型反义核酸的设计

基本信息

  • 批准号:
    07457551
  • 负责人:
  • 金额:
    $ 3.52万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1995
  • 资助国家:
    日本
  • 起止时间:
    1995 至 1997
  • 项目状态:
    已结题

项目摘要

1.Design and racemic synthesis of novel carbocyclic uridine, cytidine, adenosine and guanosine analogs (1-4), whose glycosidic torsion angle is fixed at around X=180゚ by means of the 5-membered O-cyclic structure between the base and sugar moiety, has been achieved.2.The optically active cyclopentane unit (5) has been synthesized from cyclopentadiene via asymmetric hydroboration by using (+)-diisopinocampheylborane. Then, synthesis of optically active 1-4 was performed by using compound 5 as a starting material according to the synthetic protocol for synthesis of racemic 1-4. Synthesis of (-)-1 has been achieved, and synthesis of (-)-2 and (-)-3 will be achieved in near future. However, modification of the synthetic pathway of (-)-4 is now investigating, because low solubility of the synthetic intermediates causes difficulties for their purification.3.After conversion of (-)-1 to its 3'-phosphoramidite derivative, oligodeoxynucleotides containing the (-)-1 residues (6-9) have been synt … More hesized by means of automated DNA synthesizer. Resistance to 3'-venome phosphodiesterase digestion and hybridization properties towards (dA)_<12> and (rA)_<12> of these oligodeoxynucleotides have been evaluated.5'-TTTTTTTTTTTT-3' (6) 5'-TTTTTcUcUTTTTT-3' (8)5'-TTTTTTcUTTTTT-3' (7) 5'-cUcUcUcUcUcUcUcUcUcUcUcU-3' (9) cU= (-)-1(1) Resistance to venome phosphodiesterase digestionUnder the conditions 6 is hydrolyzed by the enzyme in a few minutes, 9 was not hydrolyzed at all. In the case of 7 and 8, the sequence between the cU residue and the 3'-end thymine residue was hydrolyzed repidly, but the hydrolyze rate was greatly decreased at the cU residue.(2) Hybridization properties with the complementary sequencesTm values of 7 and 8 were lowered by more than 10゚C per substitution compared to 6, independent of salt concentration. On the other hand, 9 was not be able to hybridize with (dA)_<12> and (rA)_<12> at low salt concentration, however, formed a stable duplex only with (rA)_<12> at high salt conditions. Less
1.设计并外消旋合成了新型碳环尿苷、胞苷、腺苷和鸟苷类似物(1-4),其糖苷扭转角通过碱基和糖基之间的5元O-环结构固定在X=180 °附近。2.以环戊二烯为原料,通过(+)-二异松基硼烷的不对称硼氢化反应合成了光学活性环戊烷单元(5)。然后,根据用于合成外消旋1-4的合成方案,通过使用化合物5作为起始材料来进行光学活性1-4的合成。(-)-1的合成已经完成,(-)-2和(-)-3的合成将在不久的将来实现。3.将(-)-1转化为3 '-亚磷酰胺衍生物后,合成了含(-)-1残基的寡脱氧核苷酸(6-9),并对其进行了结构分析,发现(-)-4的合成途径存在缺陷,需要进一步改进。 ...更多信息 通过自动化DNA合成仪进行了合成。已经评估了这些寡聚脱氧核苷酸对3 '-毒液磷酸二酯酶消化的抗性以及对(dA)_<12>和(rA)_<12>的杂交特性。5'-TTTTTTTTTTTT-3'(6)5'-TTTTTcUcUTTTTT-3'(8)5'-TTTTTTcUTTTTT-3'(7)5'-cUcUcUcUcUcUcUcUcUcUcUcUcUcU-3'(9)cU=(-)-1(1)对毒液磷酸二酯酶消化的抗性在6在几分钟内被酶水解的条件下,9根本没有被水解。在7和8的情况下,cU残基和3 '端胸腺嘧啶残基之间的序列被快速水解,但在cU残基处水解速率大大降低。(2)与互补序列的杂交特性Tm值为7和8相比,每个取代降低了10 μ C以上,与盐浓度无关。9在低盐条件下不能与(dA)_<12>和(rA)_<12>杂交,而在高盐条件下只能与(rA)_形成稳定的双链体<12>。少

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hidehito Urata et al.: "Design and Racemic Synthesis of Conformationally Restricted CarbocyclicPyrimidine Nucleoside Analogs Based on the Structure of the L-Nucleoside Residue in Heterochiral DNA" Chem.Pharm.Bull.46 (in press). (1998)
Hidehito Urata 等人:“基于异手性 DNA 中 L-核苷残基结构的构象限制性碳环嘧啶核苷类似物的设计和外消旋合成”Chem.Pharm.Bull.46(印刷中)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hidehito Urata et al.: "Sequence Dependence of Thermodynamic Stability of Heterochiral DNA" Tetrahedron Letters. 37. 5551-5554 (1996)
Hidehito Urata 等人:“异手性 DNA 热力学稳定性的序列依赖性”四面体快报。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hirofumi Ohishi et al.: "The Crystal Structure of ((]SY.+-。[)) -Cyclocytidine Analogue Having a Low Anti Conformation Around Glycosyl Bond" Acta Crystallographica Section C. (in press). (1998)
Hirofumi Ohishi 等人:“糖基键周围具有低反构象的 ((]SY.+-.[)) -环胞苷类似物的晶体结构”《晶体学报》C 部分(出版中)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hidehito Urata, et al.: "Sequence Dependence of Thermodynamic Stability of Heterochirai DNA" Tetrahedron Letters. 37. 5551-5554 (1996)
Hidehito Urata 等人:“异手性 DNA 热力学稳定性的序列依赖性”四面体快报。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

URATA Hidehito其他文献

URATA Hidehito的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('URATA Hidehito', 18)}}的其他基金

Recognition of metal-mediated base pairs by DNA polymerases
DNA 聚合酶对金属介导的碱基对的识别
  • 批准号:
    24550199
  • 财政年份:
    2012
  • 资助金额:
    $ 3.52万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

靶向 TTR 的新型 Oligonucleotide-GalNAc 偶联物的高效构建与设计
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
oligonucleotide探针及弗氏菌根际生态的研究
  • 批准号:
    39170048
  • 批准年份:
    1991
  • 资助金额:
    3.8 万元
  • 项目类别:
    面上项目

相似海外基金

Development of programmable nanomachines towards the enzymatic synthesis of peptide oligonucleotide conjugates
开发用于肽寡核苷酸缀合物酶促合成的可编程纳米机器
  • 批准号:
    EP/X019624/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.52万
  • 项目类别:
    Fellowship
AltOligo: Alternative chemistry for oligonucleotide synthesis using Nanostar Sieving
AltOligo:使用 Nanostar 筛分合成寡核苷酸的替代化学方法
  • 批准号:
    10062368
  • 财政年份:
    2023
  • 资助金额:
    $ 3.52万
  • 项目类别:
    EU-Funded
Single molecule oligopeptide fingerprinting based on templated self-assembly of oligonucleotide structures
基于寡核苷酸结构模板化自组装的单分子寡肽指纹识别
  • 批准号:
    10838153
  • 财政年份:
    2023
  • 资助金额:
    $ 3.52万
  • 项目类别:
SynaptixBio: Development of antisense oligonucleotide therapeutics for the treatment of rare paediatric TUBB4A-related leukodystrophies
SynaptixBio:开发反义寡核苷酸疗法,用于治疗罕见的儿科 TUBB4A 相关脑白质营养不良
  • 批准号:
    10067962
  • 财政年份:
    2023
  • 资助金额:
    $ 3.52万
  • 项目类别:
    Collaborative R&D
MICA: Single-domain antibody oligonucleotides conjugates for brain delivery of oligonucleotide therapeutics
MICA:单域抗体寡核苷酸缀合物,用于脑部递送寡核苷酸治疗剂
  • 批准号:
    MR/X004686/1
  • 财政年份:
    2023
  • 资助金额:
    $ 3.52万
  • 项目类别:
    Fellowship
Development of efficient synthetic methods for artificial nucleic acids aimed at improving activity and reducing toxicity of oligonucleotide medicines
开发人工核酸的有效合成方法,旨在提高寡核苷酸药物的活性并降低毒性
  • 批准号:
    23K04930
  • 财政年份:
    2023
  • 资助金额:
    $ 3.52万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
IND Enabling Non-Clinical Development of E1v1.11, a Morpholino Anti-Sense Oligonucleotide for the treatment of Spinal Muscular Atrophy.
IND 促进 E1v1.11 的非临床开发,E1v1.11 是一种用于治疗脊髓性肌萎缩症的吗啉代反义寡核苷酸。
  • 批准号:
    10569744
  • 财政年份:
    2023
  • 资助金额:
    $ 3.52万
  • 项目类别:
Development of antisense oligonucleotide therapy for Schaaf-Yang syndrome humanized model mouse
Schaaf-Yang综合征人源化模型小鼠反义寡核苷酸疗法的开发
  • 批准号:
    23K14957
  • 财政年份:
    2023
  • 资助金额:
    $ 3.52万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Myeloid cell-selective, oligonucleotide-based STAT3 inhibition combined with total marrow and lymphoid irradiation for immunotherapy of acute myeloid leukemia
骨髓细胞选择性、基于寡核苷酸的 STAT3 抑制联合全骨髓和淋巴照射用于急性髓系白血病的免疫治疗
  • 批准号:
    10752538
  • 财政年份:
    2023
  • 资助金额:
    $ 3.52万
  • 项目类别:
Intellegens: Developing a novel ML-driven tool to advance Oligonucleotide-therapeutic characterisation and manufacturing.
Intellegens:开发一种新颖的机器学习驱动工具来推进寡核苷酸治疗的表征和制造。
  • 批准号:
    10063439
  • 财政年份:
    2023
  • 资助金额:
    $ 3.52万
  • 项目类别:
    Collaborative R&D
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了